手术以后怎么调养？

jin776

复查结果好，真令人高兴！
祝继续保持！
有这样好的老婆，你老公真幸福。

挚友888888

今天到地方医院去配日达仙，听朋友的朋友说，公费可以配日达仙，挂了专家门诊，向医生说明要配日达仙的理由，专家听完以后说，只有在他们医院开刀、化疗的人可以一年配16支日达仙，如果在上海开刀，他们的医院是不接受从上海开过刀的病人在他们医院做化疗，因为他们专家还不能满足专家的病人，所以说，你LG开刀相信上海就叫上海医生去开日达仙，怎么这样呀？老百姓的医院成为这些医院医生垄断了，想不通，灰溜溜回家了。

风语者2

挚友888888 发表于 2013-3-16 19:57
今天将所有化验单和片子给上海东方肝胆医院医生看，遇到周主任他看了片子以后认为肝非常好，没有事情。上次 ...

放弃也是一种过程，有耐心的引导他吧。我也有好多东西还无法放弃.........

风语者2

挚友888888 发表于 2013-3-20 14:08
今天到地方医院去配日达仙，听朋友的朋友说，公费可以配日达仙，挂了专家门诊，向医生说明要配日达仙的理由 ...

这这这像话吗？简直是过分。不知新公布的国家基本医疗目录有没有日达仙，期待ing。

丑女无盐

上一次论坛太艰难了，我要用代理服务器：（所以近期上论坛少了，但一直很惦记各位朋友。挚友姐姐近来可好？从您先生复查结果看，指数很是漂亮啊！你们那里的医院太坑爹了，别跟这些人生气。希望姐夫今年的身体越来越好，姐姐一家万事如意！

挚友888888

回复 丑女无盐 的帖子

这里许多战友都喜欢你。最近到哪里去旅游了？将好看的照片贴出来，供大家欣赏。

挚友888888

回复 风语者2 的帖子

有些地区日达仙早就进医保了，但是浙江地区一年只能配16支可以进医保。宁波只能化疗以后可以配8到16支日达仙，还要看和医生的关系。

挚友888888

美国研制出新药CD47有望治愈近十种癌症

　　据英国《每日邮报》3月26日报道，美国科学家日前研制出了一种能帮助人体免疫系统摧毁癌细胞的新型药物，对乳腺癌、肠癌、前列腺癌、子宫癌、脑癌、膀胱癌、肝癌等多种癌症都有疗效。此外前期研究表明，该药物还可用于治疗血癌（白血病）。研究人员表示，若能及早使用，该药物甚至可以完全治愈恶性肿瘤疾病，且副作用极小。
　　目前这种药物仅在小白鼠身上进行了试验，研究人员希望能在两年内开始临床试验。
　　据悉，新型药物的效力集中于一种大量存在于癌细胞表面的蛋白质，这种名叫“CD47”的蛋白质能使癌细胞免于被叫作“巨噬细胞”的免疫细胞所吞噬。新药物能去掉癌细胞这一“不要吞噬我信号”，让免疫系统直接对恶性肿瘤细胞展开攻击。
　　该药物研究员，美国斯坦福大学医学院博士欧文·韦斯曼表示：“没了‘不要吞噬我信号’，小白鼠体内的几乎所有种类的人类癌细胞都不再增长，且（新药物）副作用极小。我们的研究表明，‘CD47’确为人类战胜癌症的关键。”
　　韦斯曼博士补充称，当新药物作用于小型肿瘤时“有治愈的可能”，但在某些小白鼠身上，却没有丝毫疗效。即便如此韦斯曼博士还是认为，新药物现已具备临床试验的条件，需“快速而慎重地推进”。
　　对于新药物安全性的严格要求意味着该药物的广泛应用可能还需十几年的时间，英国癌症研究会免疫学专家菲利普·阿什顿·利卡特教授认为，上述研究可能会创造全新的癌症疗法。“对传统化疗或放射性治疗已产生抵抗力的恶性肿瘤细胞将有可能通过这种新药物得到控制，但新药物还需在临床试验中证明其在人体内的效果。”
http://www.edu.cn/yi_liao_bao_xi ... 120328_759223.shtml

挚友888888

Hope of fresh treatment for seven cancers after single antibody is found to shrink tumours from all of them
By DAILY MAIL REPORTER
PUBLISHED: 18:00 GMT, 26 March 2012 | UPDATED: 00:57 GMT, 27 March 2012
Comments (40)
Share


A drug that helps the immune system to break down cancerous tumours has been developed.
It has worked on breast, bowel, prostate, ovarian, brain, bladder and liver cancers, while previous studies show it can also be used to fight some blood cancers.
If given early, the drug could even be a cure, researchers say.

The Y-shaped human antibody works by unmasking the cancer cells to the body's disease-fighting white blood cells
The antibody has so far been tested only on mice, but researchers hope to give it to people within two years.
Its effectiveness centres on a protein called CD47, which is found on the surface of cancer cells in high quantities. The protein prevents them from being engulfed and eaten by immune cells called macrophages.
The drug masks the so-called ‘don’t-eat-me signal’, allowing the immune system to attack the cancer – a goal of many researchers for decades.

Breakthrough: Professor Irving Weissman from Stanford University who made the finding
Tests on cells in the lab and on mice showed it to work on a broad range of cancers and with minimal side-effects. Given to mice with human tumours, the antibody made them shrink and, in some cases, disappear.
The journal Proceedings of the National Academy of Sciences adds that the drug ‘dramatically’ increased survival rates.
Researcher Dr Irving Weissman, from the Stanford University School of Medicine in California, said: ‘Blocking this “don’t-eat-me” signal inhibits the growth in mice of nearly every human cancer we tested, with minimal toxicity.
‘This shows conclusively that this protein, CD47, is a legitimate and promising target for human cancer therapy.’
Dr Weissman said that when used on small tumours, the drug is ‘potentially curative’ – but stressed that for some of the mice it did not work at all.
He added that there was now enough evidence to ‘move forward quickly but cautiously’ into human trials.
However, the need for extensive proof that the drug is safe as  well as effective means that  its widespread use is about a decade away.
Professor Philip Ashton-Rickardt, an expert in immunology funded by Cancer Research UK, said the research could lead to new treatments.
‘Particularly exciting is the possibility that this approach could be used to tackle cancer cells that are resistant to traditional treatments such as chemotherapy and radiotherapy,’ he said.
‘But clinical trials are needed to find out whether it will  benefit patients.’


Read more: http://www.dailymail.co.uk/healt ... .html#ixzz2PE1pS1Ut
Follow us: @MailOnline on Twitter | DailyMail on Facebook

挚友888888

自己制作健康米醋：

买白米醋一瓶+半斤大枣+半斤枸杞+半斤打碎冰糖一起泡着，烧菜的时候加一点，菜中有点酸带甜味，可以调剂食欲。